Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Get this document free

Osmetech plc (OMH) - Product Pipeline Analysis

VIEWS: 12 PAGES: 62

Osmetech plc (OMH) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Osmetech plc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy

More Info
									                                            Osmetech plc (OMH) - Product Pipeline Analysis

     Reference Code: GDME7245PD                                                                                                Publication Date: NOV 2010



    Company Snapshot                                                          Company Overview
    Key Information
                                                                              Osmetech plc (Osmetech) is engaged in the manufacturing, development,
     Osmetech plc, Key Facts                                                  design and distribution of molecular diagnostic technologies and tools.The
                                                                              flagship product of the company is eSensor XT-8 System. The XT8 system
     Web Address                            www.osmetech.com
                                                                              provides Warfarin Sensitivity Test and Cystic Fibrosis Genotyping Test. It
     Turnover (in USD Million) 1                                              operates as a wholly owned subsidiary of GenMark Diagnostics, Inc. It
                                                                              principally operates in the US. The company is headquartered in London,
     Number of Employees                    64                                England
     Industry                               Pharmaceuticals and Healthcare-
     Source:Primary / Secondary Research
     GlobalData



    Osmetech plc Pipeline Products

     Osmetech plc Key Pipeline Products by Equipment Type                     Osmetech plc Key Pipeline Products by Therapy Area

     Equipment Type                                         No of Products    Therapy Area                                               No of Products
     Immuno Chemistry                                             4           Cerebrovascular diseases, Coronary artery disease,            1
     Infectious Immunology                                                    Peripheral vascular disease
                                                                  1
                                                                              Respiratory tract infections                                  1
     Genetic Testing                                              1
                                                                              Venous thrombosis                                             1
     Source: Primary / Secondary Research
                                                                              Source: Primary / Secondary Research
     GlobalData
                                                                              GlobalData


     Osmetech plc Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     Osmetech plc Key Pipeline Products by Development                        Osmetech plc Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                    No of Products                    Trial Phase                                                No of Products
     Clinicals                               1                                Phase IV                                               -
     Pre-Clinicals                                            -               Phase III                                              -
     Early development                                        4               Phase II                                               -
     Source: Primary / Secondary Research                                     Phase I                                                -
     GlobalData
     Note : (-) indicates 'Not Available'
                                                                              Source: Primary / Secondary Research
                                                                              GlobalData
                                                                              Note : (-) indicates 'Not Available'




Osmetech plc (OMH) - Product Pipeline Analysis                                                                                     Reference Code: GDME7245PD

Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
    Table of Contents
    Table of Contents................................................................................................................................................................................................................................................................... 2
    List of Tables .......................................................................................................................................................................................................................................................................... 3
    List of Figures......................................................................................................................................................................................................................................................................... 3
    Osmetech plc - Business Description .................................................................................................................................................................................................................................... 4
    Key Facts ............................................................................................................................................................................................................................................................................... 5
    Osmetech plc - Major Products and Services ........................................................................................................................................................................................................................ 6
          Osmetech plc Pipeline Products by Equipment Type...................................................................................................................................................................................................... 7
          Osmetech plc Pipeline Products by Development Stage ................................................................................................................................................................................................ 9
          Osmetech plc Pipeline Products by Therapy Area ........................................................................................................................................................................................................ 11
          2C19 Plavix Test............................................................................................................................................................................................................................................................ 13
                Product Status......................................................................................................................................................................................................................................................... 13
                Product Description ................................................................................................................................................................................................................................................. 13
          2D6 Drug Metabolism Test ............................................................................................................................................................................................................................................ 13
                Product Status......................................................................................................................................................................................................................................................... 13
                Product Description ................................................................................................................................................................................................................................................. 13
          Esenor Factor II, Factor V and MTHFR Test ................................................................................................................................................................................................................. 13
                Product Status......................................................................................................................................................................................................................................................... 13
                Product Description ................................................................................................................................................................................................................................................. 14
                Product Patent Details ............................................................................................................................................................................................................................................ 14
          eSensor Warfarin Sensitivity Plus Test.......................................................................................................................................................................................................................... 27
                Product Status......................................................................................................................................................................................................................................................... 27
                Product Description ................................................................................................................................................................................................................................................. 27
          Respiratory Viral Pathogen Test.................................................................................................................................................................................................................................... 27
                Product Status......................................................................................................................................................................................................................................................... 27
                Product Description ................................................................................................................................................................................................................................................. 28
                Product Patent Details ............................................................................................................................................................................................................................................ 28
          Tamoxifen Sensitivity Test............................................................................................................................................................................................................................................. 41
                Product Status......................................................................................................................................................................................................................................................... 41
                Product Description ................................................................................................................................................................................................................................................. 41
                Product Patent Details ............................................................................................................................................................................................................................................ 41
    Osmetech plc - Key Competitors ......................................................................................................................................................................................................................................... 55
    Osmetech plc - Key Employees ........................................................................................................................................................................................................................................... 56
    Osmetech plc - Key Employee Biographies......................................................................................................................................................................................................................... 57
    Osmetech plc - Locations And Subsidiaries......................................................................................................................................................................................................................... 58
          Head Office.................................................................................................................................................................................................................................................................... 58
          Other Locations & Subsidiaries ..................................................................................................................................................................................................................................... 58
    Recent Developments.......................................................................................................................................................................................................................................................... 59
                Dec 09, 2009: Osmetech Molecular Appoints John Bellano As Senior Vice President Commercial Operations .............................................................................................
								
To top